about
Harnessing the intestinal microbiome for optimal therapeutic immunomodulationAutophagy-dependent anticancer immune responses induced by chemotherapeutic agents in miceActivation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumorsAdaptive pulse shape control in a diode-seeded nanosecond fiber MOPA system.Precision medicine in breast cancer: reality or utopia?Effects of polyphenols and lipids from Pennisetum glaucum grains on T-cell activation: modulation of Ca(2+) and ERK1/ERK2 signaling.Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis.Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomasNovel chemical probes for the investigation of nonribosomal peptide assembly.AMPK Phosphorylation Modulates Pain by Activation of NLRP3 Inflammasome.Prognostic value of angiopoietin-2 for death risk stratification in patients with metastatic colorectal carcinoma.Immunogenic chemotherapy: discovery of a critical protein through proteomic analyses of tumor cells.Molecular characteristics of immunogenic cancer cell death.Use of dedicated gene panel sequencing using next generation sequencing to improve the personalized care of lung cancer.TH9 cells in anti-tumor immunity.The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?Immunomodulation and anti-inflammatory roles of polyphenols as anticancer agents.Importance of lipid microdomains, rafts, in absorption, delivery, and biological effects of resveratrol.Th9 cells: a novel CD4 T-cell subset in the immune war against cancer.The role of telomeres in predicting individual radiosensitivity of patients with cancer in the era of personalized radiotherapy.UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice.Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer.Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death.Efficiency of olaparib in colorectal cancer patients with an alteration of the homologous repair protein.Antibiotic Use Does Not Appear to Influence Response to Nivolumab.Transcription Factor Binding Studies in CD4+ T Cells: siRNA Transfection, Chromatin Immunoprecipitation, and Liquid Luminescent DNA Precipitation Assay.Dacarbazine mediate antimelanoma effects via NK cells.Socs3 induction by PPARγ restrains cancer-promoting inflammation.Tumor exosome-mediated MDSC activation.Metronomic oral cyclophosphamide prednisolone chemotherapy is an effective treatment for metastatic hormone-refractory prostate cancer after docetaxel failure.Epidemiology and prognosis of synchronous and metachronous colon cancer metastases: a French population-based study.Protective effects of polyphenol-rich infusions from carob (Ceratonia siliqua) leaves and cladodes of Opuntia ficus-indica against inflammation associated with diet-induced obesity and DSS-induced colitis in Swiss mice.Correction: SNP Array Analysis Reveals Novel Genomic Abnormalities Including Copy Neutral Loss of Heterozygosity in Anaplastic Oligodendrogliomas.IRF8-dependent molecular complexes control the Th9 transcriptional program.Bevacizumab Maintenance Versus No Maintenance During Chemotherapy-Free Intervals in Metastatic Colorectal Cancer: A Randomized Phase III Trial (PRODIGE 9).Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: a simple biological score.Inhibition of colon cancer growth by docosahexaenoic acid involves autocrine production of TNFα.Metronomic cyclophosphamide with cisplatin and bevacizumab: a new chemotherapeutic regimen for refractory anaplastic ependymoma.Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.Correction: Novel chemical probes for the investigation of nonribosomal peptide assembly.
P50
Q27001449-DF69F143-9AEF-430E-B5BC-66359181A115Q29615615-392FD908-3BD3-4A8F-89F7-67311983B4DEQ29615665-9994A3E6-0E67-4EC5-A613-8C673D864CB2Q33468198-17410605-6982-4267-A76B-E139019AFFC5Q33809114-134A973D-16CB-4541-9469-262AA2CB2592Q35857989-AB119B80-7662-4C84-92A9-348FDE53B82BQ36085651-5336604A-C59A-46DF-98A7-99879082548AQ36196936-575125BD-631A-4351-BB2A-93EB02F51415Q36408886-B336C21D-9446-430E-B2DA-BB7D6147CD3BQ36549279-902D1CB3-7171-4EB0-B63B-25FC8282C07FQ36724011-88D2048D-69A8-4347-8917-428139D8D7FFQ36931451-A4926793-A808-488A-B00D-7E210953C1C5Q37002804-12244650-B9AB-447A-A2AF-96D5C7FE8ABDQ37269473-DFD127BE-C5C8-4DC6-9CCC-FCFED445357CQ37575177-B34BA8CE-D0C3-4E7E-86CE-373174A3B4DDQ37709203-0F4F8105-76E3-4058-89FC-BCD4DF09493CQ37980226-F8E9779F-EE5C-4E1B-A6EF-32D92B58D04EQ38121601-7AF87D9B-78A2-46AE-854A-D8D592CEDE59Q38318660-A0B66E30-D28D-4586-83C6-5B0F62BF08DAQ38364096-A1B8D95D-9377-4C6E-9836-9572980D5076Q38393997-54EFD407-842F-491E-AA0E-2F77455E3B0EQ38817373-B5AF158D-096B-4B05-8034-6CD79AF5DC0AQ39180818-F28CF2DB-DA45-475A-B0B3-796BF21507E6Q40038637-3244C332-CB9E-4E1E-9D75-FB6ADC155A4BQ40182813-441E9132-F526-42B4-944E-0A12F25CBCE4Q40224202-ED29EAB9-17AB-4A07-BF8A-6E1C192493EDQ40725468-FB1DCE69-7B44-418F-9D09-0119B7F67E87Q42574046-AEA4CB10-6F22-4662-927B-7CF1C2E0030EQ42709359-89AB4B86-6A1C-4DC9-B801-BBDD43C37727Q42841495-05E1BE48-17EF-429F-9C90-134CC3466B04Q44173587-ADEFEA31-F790-41C8-92D3-EDA07E661C2DQ46386236-123A1559-E15C-407B-AC15-98C2F6E78BA6Q46934079-1CD82015-4574-4146-A56C-F13C5F9BE0E4Q47139168-F1B98EFA-5B17-40E5-AF8E-E768E193690AQ47551795-071B7838-FAF0-4912-9E3F-CFA35FB34C1DQ48136626-94E6142D-3A70-4059-BFD9-9499BF729123Q48245226-70BDDE4B-7019-47E5-BD7B-00FD699D131CQ48293473-8448F7E4-82A5-4B25-B09F-D73A06B26361Q48373246-A355816D-9BB3-465A-89C4-3FBB54017C3FQ48547127-B6B74657-9E14-458E-ACE3-FAA34638786A
P50
description
researcher ORCID ID = 0000-0002-5465-8305
@en
wetenschapper
@nl
name
Francois Ghiringhelli
@ast
Francois Ghiringhelli
@en
Francois Ghiringhelli
@es
Francois Ghiringhelli
@nl
type
label
Francois Ghiringhelli
@ast
Francois Ghiringhelli
@en
Francois Ghiringhelli
@es
Francois Ghiringhelli
@nl
prefLabel
Francois Ghiringhelli
@ast
Francois Ghiringhelli
@en
Francois Ghiringhelli
@es
Francois Ghiringhelli
@nl
P31
P496
0000-0002-5465-8305